Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Meningioma × Crossing Over, Genetic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Meningioma 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 pembrolizumab 1 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 fludarabine 1 Surgical Procedures, Operative 1 Semaxinib 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Lysine 1 Ipilimumab 1 Interleukin-2 1 Imatinib Mesylate 1 Ga(III)-DOTATOC 1 Erlotinib Hydrochloride 1 Cyclophosphamide 1 Crossing Over, Genetic 1 CTLA-4 Antigen 1 Arginine 1 64Cu-SARTATE 1 177Lu-octreotide, DOTA(0)-Tyr(3)- 1 177Lu-DOTA-JR11 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04997317 2025-04-13

PROMENADE

University Hospital, Basel, Switzerland

Phase 1/2 Recruiting

Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡